Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1901
Similarweb
SMWB
$767M
| $2.79M | ﹤0.01% |
355,573
+77,300
| +28% | +$579K |
2022 Q2
12 quarters
|
|
1902
Alerian MLP ETF
AMLP
$12.7B
| $2.79M | ﹤0.01% |
57,000
+14,700
| +35% | +$713K |
2025 Q1
1 quarter
|
|
1903
TPG RE Finance Trust
TRTX
$443M
| $2.78M | ﹤0.01% |
360,099
-149,900
| -29% | -$1.14M |
2018 Q3
27 quarters
|
|
1904
DELISTED
Thermon Group Holdings
THR
| $2.78M | ﹤0.01% |
99,000
-4,900
| -5% | -$133K |
2013 Q2
48 quarters
|
|
1905
First Bancorp
FNLC
$379M
| $2.78M | ﹤0.01% |
109,263
-400
| -0.4% | -$9.7K |
2013 Q2
48 quarters
|
|
1906
Monte Rosa Therapeutics
GLUE
$844M
| $2.77M | ﹤0.01% |
615,100
+451,000
| +275% | +$2.01M |
2022 Q4
10 quarters
|
|
1907
Panagram BBB-B CLO ETF
CLOZ
$785M
| $2.77M | ﹤0.01% |
+103,527
| New | +$2.74M |
2025 Q2
0 quarters
|
|
1908
TWFG Inc
TWFG
$312M
| $2.77M | ﹤0.01% |
79,000
-17,444
| -18% | -$582K |
2024 Q4
2 quarters
|
|
1909
TPG Mortgage Investment Trust
MITT
$174M
| $2.76M | ﹤0.01% |
366,141
-55,099
| -13% | -$381K |
2020 Q4
18 quarters
|
|
1910
SR Bancorp
SRBK
$136M
| $2.76M | ﹤0.01% |
204,100
+59,400
| +41% | +$764K |
2023 Q4
6 quarters
|
|
1911
Peoples Bancorp
PEBO
$1.29B
| $2.75M | ﹤0.01% |
90,054
+50,168
| +126% | +$1.47M |
2024 Q3
3 quarters
|
|
1912
Paysafe
PSFE
$300M
| $2.74M | ﹤0.01% |
217,389
-63,800
| -23% | -$873K |
2021 Q4
14 quarters
|
|
1913
Definitive Healthcare
DH
$105M
| $2.74M | ﹤0.01% |
703,431
+403,691
| +135% | +$1.27M |
2024 Q1
5 quarters
|
|
1914
Covenant Logistics
CVLG
$798M
| $2.74M | ﹤0.01% |
+113,600
| New | +$2.46M |
2025 Q2
0 quarters
|
|
1915
Denali Therapeutics
DNLI
$2.94B
| $2.74M | ﹤0.01% |
195,700
+22,600
| +13% | +$318K |
2025 Q1
1 quarter
|
|
1916
Fulton Financial
FULT
$4.19B
| $2.74M | ﹤0.01% |
+151,645
| New | +$2.59M |
2025 Q2
0 quarters
|
|
1917
TriMas Corp
TRS
$1.38B
| $2.74M | ﹤0.01% |
+95,600
| New | +$2.35M |
2025 Q2
0 quarters
|
|
1918
Cathay General Bancorp
CATY
$3.96B
| $2.72M | ﹤0.01% |
59,771
-6,700
| -10% | -$285K |
2025 Q1
1 quarter
|
|
1919
Insteel Industries
IIIN
$588M
| $2.71M | ﹤0.01% |
72,840
-5,800
| -7% | -$194K |
2023 Q4
6 quarters
|
|
1920
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.99B
| $2.69M | ﹤0.01% |
82,700
+28,600
| +53% | +$918K |
2025 Q1
1 quarter
|
|
1921
American States Water
AWR
$3.27B
| $2.69M | ﹤0.01% |
+35,100
| New | +$2.76M |
2025 Q2
0 quarters
|
|
1922
Natural Health Trends
NHTC
$8.24M
| $2.69M | ﹤0.01% |
621,415
-18,000
| -3% | -$86.4K |
2015 Q1
41 quarters
|
|
1923
Defiance Quantum ETF
QTUM
$5.57B
| $2.69M | ﹤0.01% |
29,300
+21,100
| +257% | +$1.71M |
2025 Q1
1 quarter
|
|
1924
MasterCraft Boat Holdings
MCFT
$477M
| $2.69M | ﹤0.01% |
144,656
+2,000
| +1% | +$34.2K |
2021 Q4
14 quarters
|
|
1925
Accenture
ACN
$131B
| $2.68M | ﹤0.01% |
8,972
-307,628
| -97% | -$93.7M |
2024 Q4
2 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.